GlassScriptPhysician profile
Audrey E Haywood
NPI 1356696041
$1,695.84
in general payments reported to CMS, 2019-2025
14 companies · $126 in 2025
The $126 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,262 · 2020: $88.39 · 2021: $11.56 · 2022: $114 · 2023: $61.43 · 2024: $32.48 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155 · Education: $64.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $154.84 |
| Education | $64.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $445.52 | 2019-2020 | |
| Insmed, INC. | $411.86 | 2019-2025 | Arikayce, Brinsupri |
| Astrazeneca Pharmaceuticals LP | $171.88 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $123.14 | 2019 | |
| Alexion Pharmaceuticals, INC. | $122.07 | 2019 | |
| La Jolla Pharmaceutical Company | $118.41 | 2019 | |
| Viatris Specialty LLC | $98.21 | 2025 | Tobi Podhaler |
| Merck Sharp & Dohme LLC | $87.45 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $30.49 | 2019 | |
| Grifols USA, LLC | $23.72 | 2022 | |
| Ethicon INC. | $18.31 | 2022 | |
| Genentech USA, INC. | $15.64 | 2019 | |
| Chiesi USA, INC. | $15.01 | 2019 | |
| Mylan Specialty L.P. | $14.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Haywood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.